Seeking Alpha

Dendreon (DNDN) yesterday confirmed that the SEC has opened an investigation, which could be...

Dendreon (DNDN) yesterday confirmed that the SEC has opened an investigation, which could be connected to lawsuits accusing the company of misleading investors over Provenge. While Dendreon had initially been bullish about the prostate-cancer treatment, it shocked the market in August 2011 when it said that adoption was slow, causing Dendreon's stock to plunge over 65% in one day.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs